Poster: MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf)

Evangelos Terpos,Ashraf Badros,Rakesh Popat,Paula Rodriguez-Otero,Asim Farooq,Bennie Jeng,Simona Degli Esposti,Eric Lewis,Ira Gupta,Joanna Opalinska,Antonio Palumbo,Suzanne Trudel

doi:10.1016/s2152-2650(21)01577-9

Poster: MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf)

Evangelos Terpos, Ashraf Badros + Show 10 more

Open Access

https://doi.org/10.1016/s2152-2650(21)01577-9

Copy DOI

Journal: Clinical Lymphoma Myeloma and Leukemia

Publication Date: Aug 30, 2021

Affiliation: National and Kapodistrian University of Athens, University of Maryland, Baltimore, University College London Hospitals NHS Foundation Trust, University of Chicago Medical Center, Moorfields Eye Hospital NHS Foundation Trust, Research Triangle Park Foundation, GlaxoSmithKline (United States), Providence College, Princess Margaret Cancer Centre

#Relapsed Or Refractory Multiple Myeloma #Ocular Symptoms In Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Poster: MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Clinical Lymphoma Myeloma and Leukemia

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.